| 12 months | LOCF | ||||
---|---|---|---|---|---|---|
ANCOVA | Placebo | Green tea | P-value | Placebo | Green tea | P-value |
FAS | N = 16 | N = 17 |  | N = 16 | N = 17 |  |
Total MMSE-J Score, LSM ± SE | 1.04 ± 0.80 | 0.42 ± 0.77 | 0.59 | 0.71 ± 0.71 | 0.13 ± 0.66 | 0.56 |
LSM difference [95 % CI] | −0.61 [−2.97, 1.74] |  | −0.59 [−2.62, 1.45] |  | ||
PPS | N = 13 | N = 13 |  | N = 13 | N = 13 |  |
Total MMSE-J Score, LSM ± SE | 1.04 ± 0.83 | 0.46 ± 0.83 | 0.64 | 1.03 ± 0.82 | 0.36 ± 0.79 | 0.57 |
LSM mean difference [95 % CI] | −0.58 [−3.08, 1.92] |  | −0.67 [−3.10, 1.76] |  | ||
Repeated measures ANCOVA | ||||||
FAS | LSM ± SE | LSM difference ± SE | P-value | |||
 Placebo | 0.75 ± 0.68 | −0.33 ± 0.94 | 0.73 | |||
 Green tea | 0.42 ± 0.63 |  |  | |||
PPS | ||||||
 Placebo | 1.16 ± 0.70 | −0.67 ± 1.00 | 0.51 | |||
 Green tea | 0.49 ± 0.67 |  |  |